CHARLOTTE, N.C., May 7, 2009 (GLOBE NEWSWIRE) -- HealthSport, Inc. (OTCBB:HSPO), announced today that it has entered into an agreement to develop four initial nutraceutical products using Innozen's proprietary concentrated liquid drops. Initial laboratory samples of the liquid drop products will be delivered before May 14, 2008 for consumer testing.
"We have received several inquiries requesting information on our proprietary encapsulated technology and concentrated formulation technology. This agreement to develop various nutraceutical and homeopathic products marks our first contract to develop products for retail sales. The initial four products are currently in development, but initial lab samples are very promising," stated Hank Durschlag, CEO of HealthSport, Inc.
"Our research and development team continues to advance new drug and nutraceutical delivery systems, and Innozen's proprietary concentrated liquid drop technology will complement our patent-pending edible thin film strips, giving HealthSport a wide spectrum of product and marketing options," continued Mr. Durschlag.
About HealthSport, Inc.
HealthSport, Inc. (http://healthsportinc.com) is a fully integrated developer, manufacturer and marketer of unique and proprietary branded and private label edible film strip nutritional supplements and over-the-counter drugs. HealthSport's wholly-owned subsidiary, InnoZen, Inc. (http://www.innozen.com), is the preeminent formulator, developer and manufacturer of edible film strips that deliver drug actives through buccal (between the cheek and gum) absorption. InnoZen's proprietary edible film strip delivery technology is superior to any other competitive edible film strips currently available on the market. InnoZen has five patents pending and has developed numerous trade secrets which it incorporates in the development and manufacturing process of edible film strips.
Forward-Looking Statements in this news release are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to certain risks, and uncertainties and actual results could differ from those discussed. This material is information only, and is not an offer or solicitation to buy or sell the securities.